What are biopharma's greatest skilled manufacturing labor needs, and what's the industry doing to fill them? John Balchunas is on the front lines in his position as Workforce Director at NIIMBL, the National Institute for Innovation in Manufacturing Biopharmaceuticals, and he says advanced degrees and pedigrees aren't the answer. The breadth and...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has announced the selection of 44 college freshman and sophomores to participate in the 2023 NIIMBL eXperience Program, the largest cohort to date since the program launched in 2019. Students were selected from 34 educational institutions across the United States to...

The Biden-Harris Administration submitted to Congress the President’s Budget for fiscal year 2024. President Biden’s 2024 Budget for the Department of Commerce makes historic investments to drive U.S. innovation and global competitiveness, foster inclusive capitalism and equitable economic growth, address the climate crisis, and expand opportunity...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) launches NIIMBL bioLOGIC, a pilot program designed to bring awareness to and foster interest in careers in the biopharmaceutical manufacturing industry. NIIMBL has partnered with the North Carolina Biotechnology Center and has selected Southern High School of Energy...

The world can’t stop talking about biopharma’s scientific achievements, but the discussion often avoids the industry’s biggest potential buzzkill: a shortage of properly trained workers to manufacture these new drugs.

There’s no denying that biopharma drugs will play a vital role in the future of medicine. Biologics make up about 40 percent of the...